Project CBD
MARCH 21, 2023
5 As far as human studies, the review authors also summarize two previous surveys in 2010 and 2019, a 1975 clinical trial and a 2006 case study — whose cumulative findings are, at best, entirely unclear. While the collective evidence to date is mixed and inconclusive, it’s also incomplete.
Project CBD
FEBRUARY 27, 2023
Researchers have been investigating the use of cannabis to treat fibromyalgia’s constellation of symptoms for decades, with early clinical trials in the 2000s 1-4 suggesting a possible benefit of both pure THC and flower in managing the disease. 22,7 (2006): 1269-76. It’s not a new idea. That seemed to make all the difference.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
MARCH 20, 2023
In 2006, the first research paper by Johns Hopkins was published on the positive long-term impact of using psilocybin in a therapeutic study. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Missouri Rep. Texas This year, Texas Gov.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.
Cannabis Law Report
AUGUST 7, 2022
In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. But these substances remain illegal under federal law.
Greencamp
FEBRUARY 2, 2019
But I haven’t seen any clinical trials looking at the direct effects of THC on the virus. Rock RB, Gekker G, Hu S, Sheng WS, Cabral GA, Martin BR, Peterson PK; WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors; 2006.
Healer
DECEMBER 17, 2021
Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. 2006): 349-353. The key takeaways for you to remember are: CBD is unlikely to cause drug interactions at low and moderate doses used by most consumers of artisanal products.
Expert insights. Personalized for you.
144 
Let's personalize your content